Heart and Vessels

, Volume 24, Issue 4, pp 287–293 | Cite as

Treatment strategy and clinical outcome in Japanese patients with atrial fibrillation

  • Shinya Suzuki
  • Takeshi Yamashita
  • Takayuki Otsuka
  • Koichi Sagara
  • Tokuhisa Uejima
  • Yuji Oikawa
  • Junji Yajima
  • Akira Koike
  • Kazuyuki Nagashima
  • Hajime Kirigaya
  • Ken Ogasawara
  • Hitoshi Sawada
  • Tsutomu Yamazaki
  • Tadanori Aizawa
Original Article

Abstract

Many large-scale randomized control trials (RCTs) have been performed regarding treatment strategy in atrial fibrillation (AF) in Western countries and also in Japan. However, limited data are available concerning real-world relationships between the treatment strategy and prognosis of AF patients. Out of a prospective cohort of The Shinken Database 2004 (n = 2 412), 286 AF patients (male 205, 64.1 ± 12.3 years, paroxysmal form 165) were retrospectively investigated. The percentage of AF patients under the rhythm control strategy was evaluated using the Kaplan-Meier method, which showed the cumulative proportion of rhythm control strategy was ∼30% at the 90th day after the initial visit and 40.0% at 1 year. The average time to the first rhythm control strategy was 68.3 ± 106.7 days. Those under rhythm control strategy were associated with fewer coexisting organic cardiac diseases, a younger age, and smaller left atrial dimension. Consequently, they showed very good prognosis (cumulative incidence rate of cardiovascular events at 1 year was 0.0%). Careful induction of rhythm control strategy, which was adopted in ∼40% of the patients in the real world, was associated with fewer comorbidities and therefore might lead to better prognosis, although this does not mean the direct effects of rhythm control strategy.

Key words

Atrial fibrillation Prognosis Rhythm control Epidemiology Morbidity 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Wolf PA, Abbott RD, Kannel WB (1991) Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22:983–988PubMedGoogle Scholar
  2. 2.
    Benjamin EJ, Wolf PA, D’Agostino RB, Silbershatz H, Kannel WB, Levy D (1998) Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 98:946–952PubMedGoogle Scholar
  3. 3.
    Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, D’Agostino RB, Murabito JM, Kannel WB, Benjamin EJ (2003) Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 107:2920–2925CrossRefPubMedGoogle Scholar
  4. 4.
    Falk RH. (2001) Atrial fibrillation. N Engl J Med 344:1067–1078CrossRefPubMedGoogle Scholar
  5. 5.
    Fuster V, Ryden LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, Halperin JL, Kay GN, Klein WW, Levy S, McNamara RL, Prystowsky EN, Wann LS, Wyse DG, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Russell RO, Smith SC, Klein WW, Alonso-Garcia A, Blomstrom-Lundqvist C, De Backer G, Flather M, Hradec J, Oto A, Parkhomenko A, Silber S, Torbicki A, American College of Cardiology/American Heart Association/European Society of Cardiology Board. (2001) ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol 38:1231–1266CrossRefPubMedGoogle Scholar
  6. 6.
    Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, Greene HL, Mickel MC, Dalquist JE, Corley SD, Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators (2002) A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347:1825–1833PubMedGoogle Scholar
  7. 7.
    Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, Said SA, Darmanata JI, Timmermans AJ, Tijssen JG, Crijns HJ, Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group (2002) A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 347:1834–1840CrossRefPubMedGoogle Scholar
  8. 8.
    Yamashita T, Ogawa S, Aizawa Y, Atarashi H, Inoue H, Ohe T, Okumura K, Kato T, Kamakura S, Kumagai K, Kurachi Y, Kodama I, Koretsune Y, Saikawa T, Sakurai M, Sugi K, Nakaya H, Nakayama T, Hirai M, Fukatani M, Mitamura H, Yamazaki T, JRHYTHM Investigators (2003) Investigation of the optimal treatment strategy for atrial fibrillation in Japan. Circ J 67:738–741CrossRefPubMedGoogle Scholar
  9. 9.
    Lloyd-Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, Vasan RS, D’Agostino RB, Massaro JM, Beiser A, Wolf PA, Benjamin EJ (2004) Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 110:1042–1046CrossRefPubMedGoogle Scholar
  10. 10.
    Benjamin EJ, Levy D, Vaziri SM, D’Agostino RB, Belanger AJ, Wolf PA (1994) Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 271:840–844CrossRefPubMedGoogle Scholar
  11. 11.
    Suzuki S, Yamashita T, Ohtsuka T, Sagara K, Uejima T, Oikawa Y, Yajima J, Koike A, Nagashima K, Kirigaya H, Ogasawara K, Sawada H, Aizawa T (2008) Prevalence and prognosis of patients with atrial fibrillation in japan: a prospective cohort of Shinken database 2004. Circ J 72:914–920CrossRefPubMedGoogle Scholar
  12. 12.
    European Heart Rhythm Association, Heart Rhythm Society, Fuster V, Ryd’en LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Zamorano JL, American College of Cardiology, American Heart Association Task Force on Practice Guidelines, European Society of Cardiology Committee for Practice Guidelines, Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation (2006) ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol 48:854–906CrossRefPubMedGoogle Scholar
  13. 13.
    Kosior DA, Szulc M, Opolski G, Torbicki A, Rabczenko D (2006) Long-term sinus rhythm maintenance after cardioversion of persistent atrial fibrillation: is the treatment’s success predictable? Heart Vessels 21:375–381CrossRefPubMedGoogle Scholar

Copyright information

© Springer Japan 2009

Authors and Affiliations

  • Shinya Suzuki
    • 1
  • Takeshi Yamashita
    • 2
  • Takayuki Otsuka
    • 2
  • Koichi Sagara
    • 2
  • Tokuhisa Uejima
    • 2
  • Yuji Oikawa
    • 2
  • Junji Yajima
    • 2
  • Akira Koike
    • 2
  • Kazuyuki Nagashima
    • 2
  • Hajime Kirigaya
    • 2
  • Ken Ogasawara
    • 2
  • Hitoshi Sawada
    • 2
  • Tsutomu Yamazaki
    • 1
  • Tadanori Aizawa
    • 2
  1. 1.Department of Clinical Epidemiology & Systems, Graduate School of Medicinethe University of TokyoTokyoJapan
  2. 2.The Cardiovascular InstituteTokyoJapan

Personalised recommendations